Clinical trial
Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery
NCT00307515 · Ethicon, Inc., Industry · Completed
Key facts
| NCT number | NCT00307515 |
|---|---|
| Title | Evaluation of Fibrin Sealant 2 in Retroperitoneal or Intra-Abdominal Surgery |
| Official title | A Prospective, Randomized, Controlled Evaluation of Fibrin Sealant 2 (FS2) as an Adjunct to Hemostasis for Soft Tissue Bleeding During Retroperitoneal or Intra-Abdominal Surgery |
| Lead sponsor | Ethicon, Inc., Industry |
| Collaborators | OMRIX Biopharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Blood Loss, Surgical |
| Intervention type | Device, Drug |
| Interventions | Fibrin Sealant 2 (FS2), Oxidized Regenerated Cellulose (Surgicel) |
| Enrollment | 135 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 28, 2006 |
| Last update posted | Jan 9, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: